Site icon Impactiviti

Impactiviti Daily 031510



TriCor = placebo? Not good news for Abbott A popular triglyceride-lowering drug that has been taken by millions of Americans failed to prevent heart disease in a big federal study being presented todaymore

FDA to Eli Lilly/Amylin on once-weekly Byetta: No.

OSI to Astellas: No.

FDA to Plavix (from BMS and Sanofi): black-box warning.


Negotiations Training/Presentation Training – Your sales people, account managers, leaders and executives need  to grow in these skills. We’ve got the partners you need in the Impactiviti network. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.


You’ve heard all about reach and frequency. How about each and recently? And, when it comes to Pharma and Social Media: One or Many?


Dogs filmed at 1,000 frames per second. You’ve never seen dogs jump quite like this before.


Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)


Exit mobile version